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Macroautophagy (herein referred to as autophagy) is an evolutionarily conserved mechanism of
adaptation to adverse microenvironmental conditions, including limited nutrient supplies. Several
sensors interacting with the autophagic machinery have evolved to detect fluctuations in keymeta-
bolic parameters. The signal transduction cascades operating downstream of these sensors are
highly interconnected to control a spatially and chronologically coordinated autophagic response
that maintains the health and function of individual cells while preserving organismal homeostasis.
Here, we discuss the physiological regulation of autophagy by metabolic circuitries, as well as
alterations of such control in disease.Introduction
Macroautophagy (hereafter referred to as autophagy) involves
the sequestration of cytoplasmic components (which can be
entire organelles, lipid vesicles, or protein aggregates) within a
double-membraned vesicle, the so-called autophagosome. Au-
tophagosomes fuse with lysosomes to generate autolysosomes,
in which the autophagic cargo is degraded by acidic hydrolases.
Autophagy relies on a machinery that operates in a tightly
coordinated fashion and includes: (1) a multiprotein complex
organized around unc-51-like autophagy activating kinase 1
(ULK1), RB1-inducible coiled-coil 1 (RB1CC1, best known
as FIP200), autophagy-related 13 (ATG13), and ATG101, which
triggers autophagy when the mechanistic target of rapamycin
(MTOR) complex 1 (mTORC1) is inhibited; (2) a second multipro-
tein complex involving (among several interactors) phosphatidy-
linositol 3-kinase, catalytic subunit type 3 (PIK3C3, best known
as vacuolar protein sorting 34, VPS34), Beclin 1 (BECN1), and
autophagy/beclin-1 regulator 1 (AMBRA1), which favors the
nucleation of autophagosome precursors (so-called isolation
membranes or phagophores) when inhibitory signals from antia-
poptoticmembers of the Bcl-2 protein family are blocked; (3) two
transmembrane proteins, ATG9 and vacuole membrane protein
1 (VMP1), which recycle between the Golgi apparatus, endo-
somes, and autophagosomes, probably facilitating the recruit-
ment of lipids to isolation membranes; (4) two ubiquitin-like
(UBL) protein conjugation systems, which cooperate to catalyze
the covalent attachment of ATG12 to ATG5 and ATG16-like 1
(ATG16L1) and that of phosphatidylethanolamine to microtu-
bule-associated protein 1 light chain 3 (MAP1LC3, best knownas LC3); (5) several soluble NSF attachment protein receptor
(SNARE)-like proteins, which promote the fusion between auto-
phagosomes and lysosomes; and (6) various lysosomal enzymes
that hydrolyze complex carbohydrates, proteins, lipids, and nu-
cleic acids at low pH (for review, see Mizushima [2007]).
The primary, phylogenetically conserved role of autophagy is
presumably to maintain cellular homeostasis in conditions of
dwindling nutrient supplies and other metabolic perturbations
(e.g., hypoxia). This is achieved through the rapid mobilization
of endogenous reserves, aimed at retrieving fuel for ATP synthe-
sis as well as building blocks for essential anabolic reactions
(Singh and Cuervo, 2011), coupled to a global rewiring of intra-
cellular metabolism (Figure 1). Autophagy-deficient eukaryotic
cells are more sensitive to nutrient deprivation than their wild-
type counterparts (Kroemer et al., 2010), and established tumors
may be addicted to autophagy as a means to cope with adverse
microenvironmental conditions (Guo et al., 2013a). Moreover,
mice with genetic defects in essential components of the
autophagic machinery die shortly after birth partly because
they fail to mobilize sufficient reserves to survive the period of
starvation between placental metabolism and breast feeding
(Kuma et al., 2004).
Autophagy can be relatively nonselective, targeting to lyso-
somal degradation virtually any portion of the cytoplasm, or it
may dispose of specific subcellular compartments in a highly se-
lectivemanner (Mizushima and Komatsu, 2011). Generally, auto-
phagic responses triggered by nutrient deprivation (whichmainly
serve bioenergetic/metabolic functions) are of the former type,
although elongated mitochondria are selectively spared fromCell 159, December 4, 2014 ª2014 Elsevier Inc. 1263
Figure 1. Cell-wide Metabolic Rewiring Associated with the
Activation of Autophagy
In response to several perturbations of homeostasis, including declining levels
of nutrients, cells mount an adaptive response organized around the auto-
phagy-dependent mobilization of intracellular reserves. This response is
biphasic, as it involves rapid posttranslational modifications as well as a
transcriptional and translational reprogramming that has delayed conse-
quences. Moreover, it is accompanied by a cell-wide rewiring of multiple
metabolic circuitries, including both catabolic and anabolic pathways, which
sustains cell survival and ensures basic cellular functions in conditions of
stress. AMPK, 50 AMP-activated protein kinase; eIF2a, eukaryotic translation
initiation factor 2a; mTORC1, mechanistic target of rapamycin complex 1.degradation in this context. Conversely, organellar damage or
intracellular pathogens trigger highly selective forms of auto-
phagy (Mizushima and Komatsu, 2011). Of note, autophagy
can also actively participate in both programmed and stress-
induced instances of cell death (Galluzzi et al., 2014), but this
aspect will not be discussed further here.
Autophagy is crucial not only for adaptive responses to stress,
but also for the maintenance of cellular homeostasis in physio-
logical settings, at least in part because it mediates the removal
of potentially dangerous constituents such as protein aggre-
gates and dysfunctional mitochondria (Green et al., 2011). In
line with this notion, the activation of autophagy at the whole-
body level extends the lifespan of various model organisms,
including mice (Rubinsztein et al., 2011). Moreover, defects in
the autophagic machinery have been associated with numerous
diseases, including aging-associated pathologies, neurodegen-
eration, cancer, cardiovascular disorders, and infectious/inflam-
matory conditions, as well as metabolic problems (Table S1
available online) (Choi et al., 2013). Thus, autophagy-incompe-
tent mice develop both genetically and chemically driven neo-
plasms at a higher incidence than their autophagy-competent
counterparts (Guo et al., 2013a). Various experimental models1264 Cell 159, December 4, 2014 ª2014 Elsevier Inc.of obesity and insulin resistance are also characterized by de-
fects in hepatic autophagy that can be efficiently targeted to pre-
vent steatosis/steatohepatitis and improve insulin sensitivity
(Yang et al., 2010). This is not surprising, given the central posi-
tion occupied by the liver in the regulation of organismal meta-
bolism and the role of autophagy in the rewiring of intracellular
metabolic circuitries.
Here, we will discuss the intimate crosstalk between meta-
bolism and autophagy, placing special emphasis on the mecha-
nisms through which nutrients andmetabolic byproducts induce
or suppress autophagy at the single-cell and whole-body level,
and we will explore how the metabolic regulation of autophagy
influences organismal fitness in health and disease.
Metabolic Triggers of Autophagy
In isolated cells, autophagy is generally induced by limitations in
ATP availability or a lack of essential nutrients, including glucose
and amino acids, yet it can also be stimulated by the accumula-
tion of specific metabolites or metabolic byproducts, such as
fatty acids and ammonia (Figure 2).
Reduced Energy Charge
Themetabolic status of a cell can be represented by the ‘‘energy
charge’’ of the adenylate system (a function of intracellular ATP,
ADP, and AMP concentrations), which is calculated according to
the formula ([ATP] + 1/2 [ADP])/([ATP] + [ADP] + [AMP]) (Atkinson
andWalton, 1967). When ATP is not actively synthesized though
glycolysis or oxidative phosphorylation, the energy charge
decreases in parallel with the accumulation of AMP, a condition
that stimulates autophagy through protein kinase, AMP-acti-
vated (PRKA, best known as 50 AMP-activated protein kinase,
AMPK) (Hardie et al., 2012). Because AMPK utilizes ATP as a
donor of phosphate groups and because several steps in the au-
tophagic cascade consume energy, a minimum amount of ATP
is required for the induction of autophagy. Thus, a rapid reduc-
tion of the energy charge below a critical limit is likely to trigger
cell death rather than an adaptive autophagic response (Galluzzi
et al., 2014). In cells that mostly rely on glycolysis, withdrawing
glucose promotes autophagy as a result of AMP accumulation
and the consequent activation of AMPK (Hardie et al., 2012).
However, the inhibition of hexokinase 2 (HK2, the enzyme that
catalyzes the first, rate-limiting step of glycolysis) with 2-deoxy-
glucose does not have the same effect because HK2 directly
promotes autophagy by physically interacting and hence inhibit-
ing mTORC1 (Roberts et al., 2014). Similarly, rotenone, a widely
employed inhibitor of the respiratory chain, inhibits mitochon-
drial ATP synthesis but paradoxically inhibits autophagic flux
(Mader et al., 2012). Thus, using toxins may not be an appro-
priate approach to probe complex circuitries such as those
linking metabolism and autophagy. Of note, starvation, as well
as hypoxia, are generally associated with increased amounts
of reactive oxygen species (ROS). ROS promote autophagy by
several mechanisms, including: (1) the hypoxia-inducible factor
1 (HIF-1)-dependent transactivation of BCL2/adenovirus E1B
19 kDa interacting protein 3 (BNIP3) and BNIP3-like (BNIP3L),
encoding two Bcl-2 family members that potently stimulate the
autophagic removal of dysfunctional mitochondria (mitophagy);
(2) the ataxia-telangiectasia mutated (ATM)-dependent activa-
tion of tuberous sclerosis 2 (TSC2), a major suppressor of
Figure 2. Metabolic Regulation of Auto-
phagy at the Single-Cell Level
Several changes in the availability of nutrients in
extracellular fluids trigger autophagy (directly or
indirectly), including drops in the levels of glucose,
amino acids, acetyl-CoA, and iron and decreases
in the relative abundance reduced versus oxidized
NAD, as well as the accumulation of specific lipids
and ammonia (NH4, a product of amino acid
catabolism). Many of these metabolic cues stim-
ulate autophagy because they inhibit mechanistic
target of rapamycin complex 1 (mTORC1) or
various acetyltransferases or because they acti-
vate 50 AMP-activated protein kinase (AMPK),
deacetylases of the sirtuin family, or eukaryotic
translation initiation factor 2a (eIF2a) kinases. In
addition, the accumulation of lipids may directly
favor the formation of autophagosomes in a
patatin-like phospholipase-domain-containing
5 (PNPLA5)-dependent fashion, whereas the
depletion of iron has autophagy-stimulating effects upon the recognition of ferritin heavy and light chains by the autophagic adaptor nuclear receptor coactivator
4 (NCOA4). Both mTORC1 and AMPK regulate autophagy by controlling the activity of essential components of the autophagic machinery, such as unc-51 like
autophagy activating kinase 1 (ULK1) or Beclin 1 (BECN1). Moreover, they are both involved inmutually regulatory interactions as well as in functional interactions
with other nutrient sensors, such as sirtuins. ATF4, activating transcription factor 4; ATG, autophagy-related; FOXO1, forkhead box O1; NAMPT, nicotinamide
phosphoribosyltransferase; RPTOR, regulatory-associated protein of MTOR, complex 1; TFEB, transcription factor EB; TSC2, tuberous sclerosis 2; VPS34,
vacuolar protein sorting 34.mTORC1 signaling; and (3) the oxidation-dependent activation
of the essential autophagic protein ATG4 (Scherz-Shouval and
Elazar, 2011). In summary, glucose deprivation and the conse-
quent alterations in energy charge and ROS levels are potent
activators of autophagy.
Reduced NADH/NAD+ Ratio
In either its oxidized (NAD+) or reduced (NADH) form, NAD is an
essential substrate for multiple metabolic circuitries, including
(but not limited to) glycolysis, the Krebs cycle, and oxidative
phosphorylation. The exposure of cells to nutrient-free condi-
tions causes the accumulation of NAD+ at the expense of
NADH, promoting autophagy upon activation of histone deace-
tylases of the sirtuin family (Houtkooper et al., 2012). Conversely,
the intracellular levels of both NAD+ and NADH fall upon the acti-
vation of NAD+-dependent enzymes such as poly(ADP-ribose)
polymerase 1 (PARP1) (Gibson and Kraus, 2012). Inhibition of
these enzymes (which preserves the endogenous levels of
NAD) aswell as the artificial supply of NADprecursors (e.g., nico-
tinamide, nicotinamide riboside) potently triggers autophagy
upon the activation of sirtuins, whose enzymatic activity critically
relies on NAD+ (Houtkooper et al., 2012). Thus, not only the rela-
tive abundance of NADH and NAD+, but also the total availability
of NAD has profound autophagy-modulatory effects.
Depletion of Cytosolic Acetyl-CoA
The exposure of mammalian cells to nutrient-free conditions for
several hours or the overnight starvation of mice causes a signif-
icant decrease in the cytosolic levels of acetyl-CoA, which corre-
lates with the induction of autophagy (Marin˜o et al., 2014). A
similar effect is observed with several pharmacological or ge-
netic interventions that inhibit (directly or by limiting substrate
availability) the synthesis of acetyl-CoA within mitochondria or
in the cytosol (Eisenberg et al., 2014; Marin˜o et al., 2014). The
depletion of cytosolic acetyl-CoA stores potently stimulates
autophagy, presumably because acetyl-CoA is the sole donor
of acetyl groups for acetyl transferases, some of which regulate
the activity of various components of the autophagic machineryat the posttranslational level (Marin˜o et al., 2014) or their synthe-
sis (by acetylating histones) (Lee et al., 2014). Conversely, when
intracellular acetyl-CoA levels are replenished artificially, starva-
tion-induced autophagy is inhibited both in vitro in cultured cells
and in vivo in mice (Marin˜o et al., 2014). Of note, the constitutive
activation of v-akt murine thymoma viral oncogene homolog 1
(AKT1, also known as PKB), which can be triggered by onco-
genic alterations such as activating mutations in Kirsten rat sar-
coma viral oncogene homolog (KRAS), promotes acetyl-CoA
synthesis upon the phosphorylation-dependent activation of
ATP citrate lyase (ACLY) (Lee et al., 2014). The consequent
inhibition of autophagy may contribute, at least in part, to the
oncogenic effects of AKT1 hyperactivation.
Depletion of Amino Acids
Limitations in the availability of nonessential amino acids can
trigger autophagy through at least four distinct, nonmutually
exclusive mechanisms. First, a drop in the intracellular abun-
dance of amino acid results in the accumulation of uncharged
tRNA species. This activates eukaryotic translation initiation
factor 2a kinase 4 (EIF2AK4, best known asGCN2), which blocks
protein synthesis and triggers autophagy via activating tran-
scription factor 4 (ATF4) (Ye et al., 2010). Second, the absence
of amino acids in the lysosomal lumen turns off an ‘‘inside-
outside’’ mechanism that promotes the recruitment of mTORC1
at the lysosomal surface and its activation (Zoncu et al., 2011).
Third, the lack of various amino acids—in particular, leucine,
glutamate, and glutamine—negatively affects intracellular
acetyl-CoA stores (Marin˜o et al., 2014), reflecting the ability of
these amino acids to efficiently feed into the Krebs cycle to
generate acetyl-CoA. Fourth, the depletion of the key metabolic
intermediate a-ketoglutarate caused by dwindling amino acid
levels promotes autophagy alongwith the inhibition of proline hy-
droxylases (but not the stabilization of HIF-1) (Dura´n et al., 2013),
reflecting the role of a-ketoglutarate as an obligate donor of hy-
droxyl groups for this class of enzymes. Proteasome inhibitors
can also cause a drop in the intracellular availability of aminoCell 159, December 4, 2014 ª2014 Elsevier Inc. 1265
acids and hence trigger autophagy. Although the relative weight
of each of these pathways has not yet been determined, it
appears plausible that all of these mechanisms contribute to
the orchestration of optimal autophagic responses upon amino
acid shortage.
Depletion of Iron
Iron is an obligate cofactor for several enzymes that catalyze
redox reactions, including components of the mitochondrial res-
piratory chain. A fraction of cytoplasmic iron is stored within
large ferritin oligomers, which can be rapidly degraded by the
autophagic machinery to serve cellular needs. Drops in the
intracellular availability of free iron (which can be mimicked by
the administration of pharmacological chelators) activate an
autophagic response that has been termed ‘‘ferritinophagy.’’
This appears to require nuclear receptor coactivator 4
(NCOA4), which operates as an autophagic receptor for the
recognition and engulfment of ferritin light and heavy chains
by LC3-containing autophagosomes (Mancias et al., 2014).
This example illustrates how autophagy can help cells to palliate
a selective micronutrient deficiency. It will be important to
explore whether similar mechanisms exist for specifically mobi-
lizing other nutrients.
Increased Ammonia Levels
Ammonia is one of the main byproducts of the catabolism of
amino acids and a potent inducer of autophagy (Eng et al.,
2010). However, in contrast to the autophagic response to
decreased amino acid availability, ammonia-induced autophagy
does not rely on ULK1/ULK2 activation (Cheong et al., 2011) or
mTORC1 inhibition (Harder et al., 2014). Rather, it seems that
ammonia triggers autophagy by activating AMPK and favoring
the endoplasmic reticulum (ER) stress response (Harder et al.,
2014). Of note, neoplastic tissues produce high levels of
ammonia as a result of an intense flux through glutaminolysis
(Galluzzi et al., 2013). At least in part, this may contribute to the
upregulation of the autophagic flux observed in some estab-
lished neoplasms (Guo et al., 2013a).
Lipids
Both saturated and unsaturated fatty acids, such as palmitate
and oleate, respectively, can stimulate autophagy, albeit through
distinct mechanisms. Palmitate-induced, but not oleate-
induced, autophagy requires EIF2AK2 (best known as PKR)
and mitogen-activated protein kinase 8 (MAPK8, best known
as JNK1) (Shen et al., 2012). Stearoyl-CoA desaturase, which
converts saturated lipids into their monounsaturated counter-
parts, is required for starvation-induced autophagy, and the
external supplementation of oleate con overcome the autopha-
gic defect induced by stearoyl-CoA desaturase inhibitors (Oga-
sawara et al., 2014). Possibly, this results from the need for lipids
in the generation of autophagosomes, a process that may rely on
the neutral lipase patatin-like phospholipase-domain-containing
5 (PNPLA5) (Dupont et al., 2014). Enterocytes transiently store
dietary lipids in triglyceride-containing droplets that localize at
the ER. Such droplets trigger an immediate autophagic response
that results in their capture by nascent autophagosomes and
their delivery to lysosomes for degradation (Khaldoun et al.,
2014). Hence, lipids can induce autophagy despite being nutri-
ents, and this may constitute an important mechanism to avoid
lipotoxicity at the cell-autonomous level.1266 Cell 159, December 4, 2014 ª2014 Elsevier Inc.Metabolic Sensors that Initiate Autophagy
AMPK
AMPK, one of the key energy sensors of the cell, is a heterotrimer
composed of a catalytic a subunit, a scaffolding b subunit, and a
regulatory g subunit, all of which are expressed in multiple vari-
ants by mammals (a1, a2, b1, b2, g1, g2, and g3). The binding of
two molecules of AMP (or ADP, with lower affinity) to the g sub-
unit inhibits the inactivating dephosphorylation of the a subunit at
T172 (Hardie et al., 2012). Hence, decreases in cellular energy
charge boost the kinase activity of AMPK. The phosphorylation
of AMPK a subunit at T172 can be catalyzed by calcium/calmod-
ulin-dependent protein kinase kinase 2, b (CAMKK2) and serine/
threonine kinase 11 (STK11, best known as liver kinase B1,
LKB1), or stimulated (probably via an indirect mechanism)
by mitogen-activated protein kinase kinase kinase 7 (MAP3K7,
best known as TAK1) (Hardie et al., 2012).
TAK1 is required for the starvation-induced phosphorylation
of AMPK and consequent autophagic response in cancer cells
in vitro (Criollo et al., 2011), as well as in hepatocytes in vivo
(Inokuchi-Shimizu et al., 2014). TAK1 activation is linked to two
additional phenomena that may stimulate autophagy, namely:
(1) the displacement of TAK1-binding protein 2 (TAB2) and
TAB3, two TAK1 coactivators, from their autophagy-inhibitory
interaction with BECN1 (Criollo et al., 2011), and (2) the activation
of the IkB kinase (IKK) complex, which stimulates autophagy by
phosphorylating the regulatory subunit of phosphoinositide-
3-kinase (PI3K), thereby reducing its localization to cell mem-
branes and enzymatic activity (Comb et al., 2012). Indeed, IKK
is required for an optimal autophagic response to starvation
in vitro (Comb et al., 2012; Criollo et al., 2011), and the ablation
of the gene coding for the IKK-subunit-conserved helix-loop-he-
lix ubiquitous kinase (CHUK, best known as IKKa), limits auto-
phagy in pancreatic acinar cells in vivo (Li et al., 2013). Under
some circumstances, AMPK can activate TAK1 (Lanna et al.,
2014), suggesting that these kinases may engage in a mutually
stimulatory amplification cascade. AMPK can also be activated
allosterically by pharmacological agents, perhaps reflecting the
existence of a hitherto unidentified (and perhaps crucial) endog-
enous metabolite that regulates its enzymatic activity. Among
other compounds, this applies to salicylate, a phenolic phyto-
hormone with analgesic, antipyretic, anti-inflammatory, and
perhaps anticancer activity (Hawley et al., 2012). Still, it remains
unclear whether the activation of AMPK is relevant to the broad
pharmacological effects of aspirin, the pro-drug of salicylate.
AMPK is a master regulator of metabolism, and it stimulates
autophagy by multiple mechanisms. Beyond inhibiting mTORC1
(see below), AMPK phosphorylates and activates ULK1 (Kim
et al., 2011), as well as various components of the BECN1/
VPS34 complex. In particular, upon glucose deprivation,
AMPK phosphorylates BECN1 on S93 and S96, which augments
the class III PI3K activity of VPS34, as well as VPS34 itself (on
T163 and S165), which inhibits its nonautophagic functions in
endosome-to-Golgi retrograde trafficking (Kim et al., 2013).
mTORC1
mTORC1 is composed of: (1) MTOR; (2) two mTORC1-specific
proteins—namely, regulatory-associated protein of MTOR,
complex 1 (RPTOR) and AKT1 substrate 1 (AKT1S1, best known
as PRAS40); and (3) several proteins that are sharedwith another
MTOR-containing complex (mTORC2), i.e., DEP-domain-con-
taining MTOR-interacting protein (DEPTOR) and MTOR-associ-
ated protein, LST8 homolog (MLST8). In response to growth
factors, mTORC1 phosphorylates eukaryotic translation initia-
tion factor 4E binding protein 1 (EIF4EBP1, best known as 4-
EBP1) and ribosomal protein S6 kinase (RPS6K, best known
as p70S6K), ultimately promoting protein synthesis (Shimobaya-
shi and Hall, 2014). Activated mTORC1 suppresses autophagy
by phosphorylating and inhibiting ULK1 (Kim et al., 2011),
AMBRA1 and ATG14 (two autophagy-stimulatory interactors of
BECN1) (Nazio et al., 2013; Yuan et al., 2013), and transcription
factor EB (TFEB, see below) (Settembre et al., 2013). Of note,
AMPK can inhibit mTORC1 (and hence promote autophagy)
indirectly by phosphorylating and activating tuberous sclerosis
2 (a negative regulator of mTORC1), as well as directly by phos-
phorylating RPTOR (Hardie et al., 2012).
The availability of amino acids positively regulates mTORC1
(and hence suppresses autophagy) via multiple pathways. For
instance, amino acids activate mTORC1 on the lysosomal
membrane from within the lumen of the organelle, a process
that involves vacuolar ATPases, a Ras-related GTP binding
(RRAG)-containing complex that has been termed ‘‘Ragulator,’’
and the mTORC1 activator Ras homolog enriched in brain
(RHEB) (Sancak et al., 2010). Artificial increases in the levels of
a-ketoglutarate, which can be achieved by the provision of gluta-
mine (via glutaminolysis) or several cell-permeant precursors
(i.e., dimethyl-a-ketoglutarate, trifluoromethylbenzyl-a-ketoglu-
tarate, 5-ethyltrifluoromethylbenzyl-a-ketoglutarate), potently
activate mTORC1 in cells depleted of amino acids (Marin˜o
et al., 2014), at least in part through such a lysosomal RHEB-
dependent pathway (Dura´n et al., 2012). Conversely, another
a-ketoglutarate precursor (i.e., 1-octyl-a-ketoglutarate) appears
to inhibit mTORC1, activate autophagy, and mediate lifespan-
extending effects (Chin et al., 2014). The authors of this report
ascribe their findings to the ability of a-ketoglutarate to inhibit
mitochondrial ATP synthesis at the level of the F1FO-ATPase.
Of note, leucine may also activate mTORC1 through the lyso-
somal RRAG-RHEB system. Indeed, leucine has been shown
to stimulate glutaminolysis by allosterically activating glutamate
dehydrogenase and to activate RRAG in the form of leucyl-tRNA
synthetase (Han et al., 2012). Recently, the lysosomal RRAG-
RHEB system has been suggested to contribute to the activation
of mTORC1 by glucose (Efeyan et al., 2013), suggesting that
AMPKmay not constitute the sole sensor of glucose deprivation.
It is important to note that mTORC1 not only represses auto-
phagy and lysosomal biogenesis, but also operates as a general
regulator of anabolic reactions (Shimobayashi and Hall, 2014).
Thus, similar to AMPK, mTORC1 controls several metabolic cir-
cuitries outside of the autophagic cascade, implying that chem-
ical mTORC1 inhibitors such as rapamycin (which is approved
for use in humans as an immunosuppressant to prevent the
rejection of solid transplants) and other compounds commonly
referred to as ‘‘rapalogs’’ have broad metabolic consequences
that are not limited to the induction of autophagy. Moreover,
mTORC1 inhibitors lose their capacity to trigger autophagy
when the downstream signaling pathways are affected by onco-
genic autophagy-suppressing alterations, such as the phos-
phorylation of BECN1 on S234 and S295 (which is catalyzedby AKT1) (Wang et al., 2012) or on Y229, Y233, and Y352, which
is catalyzed by the epidermal growth factor receptor (EGFR) (Wei
et al., 2013). This should be taken into consideration when
mTORC1 inhibitors are employed to stimulate autophagy in can-
cer cells exhibiting PI3K hyperactivation or bearing activating
mutations in EGFR.
eIF2a Kinases
The phosphorylation of eukaryotic translation initiation factor 2a
(EIF2A, best known as eIF2a) on S51 is a cardinal feature of the
so-called ‘‘integrated stress response,’’ which allows cells to
interrupt protein synthesis in response to the accumulation of
unfolded proteins in the ER and attempt to restore homeostasis
along with the activation of autophagy (Kroemer et al., 2010).
The mammalian genome codes for at least four kinases that
phosphorylate eIF2a—namely, EIF2AK1 (best known as HRI),
EIF2AK2 (best known as PKR), EIF2AK3 (best known as
PERK), and EIF2AK4 (best known as GCN2) (Silvera et al.,
2010). These kinases are activated by a variety of stimuli. Limited
heme availability or heavy metals like cadmium activate HRI.
Double-stranded RNA or high doses of palmitate stimulate
PKR. The accumulation of unfolded proteins in the ER activates
PERK. Finally, the accumulation of uncharged tRNAs boosts
the activity of GCN2 (Silvera et al., 2010). Of note, the response
of cells expressing a nonphosphorylatable mutant of eIF2a
(EIF2AS51A) to several autophagy-inducing conditions is largely
defective (Tallo´czy et al., 2002). This may indicate that the effi-
cient induction of autophagy by various stimuli requires the
transactivation of multiple genes that are controlled by ATF4,
which operates downstream of eIF2a (B’chir et al., 2013).
Thus, it appears that the integrated stress response is closely
tied to the regulation of autophagy.
Sirtuins
Sirtuins constitute a family of NAD+-dependent class III histone
deacetylases that catalyze the deacetylation of protein sub-
strates coupled to the generation of nicotinamide and 20-O-
acetyl-ADP-ribose (Houtkooper et al., 2012). The best-studied
of these enzymes, sirtuin 1 (SIRT1), is mainly located in the nu-
cleus, where it deacetylates various histones (e.g., H1, H3, and
H4) and other proteins, including transcription factors such as
p53, NF-kB, forkhead box O1 (FOXO1), FOXO3, and peroxisome
proliferator-activated receptor g, coactivator 1a (PPARGC1A)
(Houtkooper et al., 2012). Activation of SIRT1 with the natural
polyphenol resveratrol promotes autophagy and extends the
lifespan of several organisms (Lagouge et al., 2006). Moreover,
overexpression of a SIRT1 mutant that exclusively localizes to
the cytoplasm induces robust autophagic responses (Morselli
et al., 2011), indicating that SIRT1 can trigger autophagy
independently of its transcriptional functions. The cytoplasmic
effectors of SIRT1-driven autophagy remain to be precisely iden-
tified, although one single report points to a direct involvement of
ATG5, ATG7, ATG12 and LC3 (Lee et al., 2008).
Besides responding to increasing NAD+ concentrations (see
above), the enzymatic activity of SIRT1 changes as a function
of its own expression levels. Although high-fat diet and obesity
downregulate SIRT1 in several organs, both in mice and in hu-
mans, caloric restriction promotes SIRT1 expression in multiple
mouse tissues (Chalkiadaki and Guarente, 2012). Because the
ability of caloric restriction to increase lifespan is preserved inCell 159, December 4, 2014 ª2014 Elsevier Inc. 1267
Sir1+/ (but lost in Sir1/) mice (Mercken et al., 2014), such an
upregulation may not be involved in the lifespan-extending ef-
fects of interventions that activate SIRT1. However, results ob-
tained with Sir1/ mice must be taken with caution because
these animals are not born at Mendelian ratios and often exhibit
developmental defects (Cheng et al., 2003). Of note, AMPK may
activate SIRT1 by promoting the FOXO1-dependent transactiva-
tion of the gene encoding nicotinamide phosphoribosyltransfer-
ase (NAMPT), an enzyme involved in the production of NAD+
(Canto´ et al., 2009). Thus, at least under some circumstances,
SIRT1 contributes to the proautophagic activity of AMPK.
Acetyltransferases
Reductions in the intracellular pool of acetyl-CoA entail a net
decrease in global protein acetylation, both in the cytoplasm
(Marin˜o et al., 2014) and in the nucleus (Eisenberg et al., 2014).
Thus, the activity of several acetyltransferases may vary as a
function of the availability of acetyl-CoA, the sole donor of acetyl
groups for the reactions that they catalyze. One acetyltransfer-
ase that plays a critical role in the regulation of autophagy
is E1A-binding protein p300 (EP300) (Marin˜o et al., 2014). In
cell-free systems, the activity of EP300 responds to shifts in
the intracellular abundance of acetyl-CoA observed during the
physiological transition from a fed to an unfed state. Moreover,
the genetic or pharmacological inhibition of EP300 promotes
autophagy even in conditions in which acetyl-CoA is artificially
maintained at high levels (Marin˜o et al., 2014). EP300 reportedly
acetylates and inhibits several proteins of the core autophagic
machinery such as ATG5, ATG7, ATG12, and LC3 (Lee and Fin-
kel, 2009). However, it is likely that other acetyltransferases,
including members of the inhibitor of growth (ING) family,
participate in the regulation of autophagy via nuclear and cyto-
plasmic pathways (Marin˜o et al., 2014). In yeast, which lacks a
bona fide EP300 ortholog, several histone acetyltransferases
have been implicated in the transcriptional control of autophagy
(Eisenberg et al., 2009). Moreover, at least in yeast, a specific
combination of deacetylation- and acetylation-mimicking muta-
tions in histone-coding genes can cause the constitutive overex-
pression of core components of the autophagic machinery,
resulting in increased autophagic flux and lifespan extension
(Eisenberg et al., 2014).
Distinct acetyltransferases are organized in a hierarchical
manner so that the inhibition of one can be coupled to the acti-
vation of another. For example, EP300 acts as a negative regu-
lator of a tubulin acetyltransferase 1 (ATAT1, also known as
MEC17), which itself is a substrate of, and can be activated by,
AMPK. The activity of EP300 is also negatively regulated by
AMPK-dependent phosphorylation on S89 (Yang et al., 2001).
Thus, in conditions of EP300 inhibition and AMPK activation
(which are intimately linked), MEC17 promotes the hyperacetyla-
tion of a-tubulin, which has autophagy-stimulatory effects
(Mackeh et al., 2014). In summary, both deacetylation and hyper-
acetylation events contribute to autophagy, and it would be an
oversimplification to state that all acetyltransferases contribute
to the repression of autophagy.
Transcription Factors
The so-called ‘‘coordinated lysosomal expression and regula-
tion’’ (CLEAR) gene network, an ensemble of genes expressed
in a synchronized manner in response to perturbations of lyso-1268 Cell 159, December 4, 2014 ª2014 Elsevier Inc.somal activity (most of which are relevant for autophagy), is acti-
vated by transcription factors, including TFEB and its homolog
transcription factor E3 (TFE3) (Settembre et al., 2013). TFEB is
recruited to lysosomal membranes by the Ragulator, allowing
for its phosphorylation at S142 and S211. Phosphorylated
TFEB is sequestered by chaperones of the 14-3-3 family, which
actively prevent its translocation to the nucleus. Accordingly, the
substitution of TFEB S142 and S211with alanine residues results
in its constitutive translocation to the nucleus. TFEB can also be
phosphorylated on S142 by mitogen-activated protein kinase 1
(MAPK1, best known as ERK2), which indeed exerts auto-
phagy-inhibitory functions (Settembre et al., 2013). The identity
of the phosphatase that dephosphorylates TFEB at these resi-
dues remains to be elucidated.
Importantly, TFEB regulates its own transcription, implying the
existence of a self-amplificatory signaling loop that perpetuates
the autophagic response. How such a loop is turned off remains
elusive. Another transcription factor, zinc finger with KRAB and
SCAN domains 3 (ZKSCAN3), functionally antagonizes TFEB.
Thus, in response to starvation or mTORC1 inhibition, ZKSCAN3
translocates from the nucleus to the cytoplasm, and the knock-
down of ZKSCAN3 suffices to facilitate the induction of auto-
phagy. Indeed, ZKSCAN3 represses the transcription of more
than 60 TFEB target genes involved in autophagy and lysosomal
functions (Settembre et al., 2013). Whether these transcription
factors truly detect metabolic perturbations or whether they sim-
ply execute autophagic responses triggered by upstream sen-
sors such as mTORC1 remains to be determined. Irrespective
of this unknown, TFEB-induced autophagy has a central role in
disease protection, as the viral delivery of a TFEB-coding
construct to the liver prevents the hepatic accumulation of lipid
vesicles in both diet-induced and genetic models of obesity (Set-
tembre et al., 2013). Interestingly, the nematode ortholog of
TFEB (HLH-30) is required for the induction of autophagy by
longevity-extending manipulations in Caenorhabditis elegans
(Lapierre et al., 2013).
Cell-Surface Nutrient Receptors
Several G protein-coupled receptors (GPCRs) expressed on
the cell surface sample the extracellular microenvironment for
nutrient availability and signal to the autophagic machinery.
These include (but are not limited to): (1) G protein-coupled
receptor, class C, group 6,member A (GPRC6A), g-aminobutyric
acid B receptor 1 (GABBR1), calcium-sensing receptor (CASR),
heterodimeric taste receptors, and various metabotropic gluta-
mate receptors, all of which sense one or more amino acids;
(2) free fatty acid receptor 1 (FFAR1) and FFAR4, which detect
long-chain fatty acids; and (3) FFAR2 and FFAR3, which are acti-
vated by short-chain fatty acids (Wauson et al., 2014). The signal
transduction cascades linking each of these receptors to the
autophagic machinery have not yet been precisely defined, but
they all presumably operate by promoting increases in the intra-
cellular levels of inositol-1,4,5,-triphosphate and diacylglycerol,
or those of cyclic AMP (Wauson et al., 2014).
In several cell types, including pancreatic b cells, cardiacmyo-
blasts, and cervical carcinoma HeLa cells, the knockdown of
either subunit of heterodimeric taste receptors—namely, taste
receptor, type 1, member 1 (TAS1R1) and TAS1R3—promotes
autophagy even in the presence of excess extracellular amino
Figure 3. Metabolic Regulation of Auto-
phagy at the Organismal Level
Acute starvation induces a stereotyped pattern
of metabolic alterations, including a (limited)
decrease in circulating glucose levels coupled to
an increase in blood-borne triglycerides and free
fatty acids (FFAs). This is generally accompanied
by the secretion of glucagon (GCG), as well as by a
reduction in the circulating levels of growth fac-
tors, insulin (INS), insulin-like growth factor 1
(IGF1), leptin (LEP), and myonectin. FFAs trigger
autophagy as they freely enter cells and promote
the inactivation of eukaryotic translation initia-
tion factor 2a (eIF2a) coupled to the activation
of activating transcription factor 4 (ATF4).
Conversely, the alterations in the circulating levels
of INS, IGF1, GCG, and LEP induced by starva-
tion are sensed by specific receptors expressed
at the cell surface, all of which impinge on the v-akt
murine thymoma viral oncogene homolog 1
(AKT1)/mechanistic target of rapamycin complex
1 (mTORC1) signaling axis. In addition, drops in
the availability of growth factors promote auto-
phagy by limiting the expression of nutrient
transporters. Epinephrine is also secreted in
response to starvation, promoting autophagy in
the periphery upon binding to adrenoceptor b2 (ADRB2). Other hormones with prominent autophagy-regulatory functions are adiponectin (ADIPOQ) and ghrelin
(GHRL). The former, which is secreted by the adipose tissue, exerts pure autophagy stimulatory functions by inhibiting mTORC1 and promoting the activation of
50 AMP-activated protein kinase (AMPK). The latter, which is secreted upon relaxation of the gastric wall, has been shown to inhibit AMPK in some circumstances,
hence inhibiting autophagy, and to suppress proteasomal protein degradation in others, hence increasing autophagic flux. ADIPOR, ADIPOQ receptor; GCGR,
GCG receptor; GHSR1a, growth hormone secretagogue receptor 1A; IGF1R, IGF1 receptor; INSR, INS receptor; IRS, INSR substrate; LEPR, LEP receptor; PI3K,
phosphinositide-3-kinase; PKA, protein kinase A; RTK, receptor tyrosine kinase.acids. Similarly, Tas1r3/mice exhibit increased autophagic re-
sponses to starvation in the heart, liver, and skeletal muscle, as
compared to their wild-type counterparts (Wauson et al., 2012).
Indirect evidence also suggests that the omega-3 fatty acid do-
cosahexaenoic acid induces autophagy upon binding to FFAR4
on the cell surface (Williams-Bey et al., 2014). These results point
to the possibility that GPCRs not only sense nutrients in the ol-
factory and gustative sensory organs, but also act in peripheral
tissues to regulate autophagy in response to extracellular meta-
bolic cues.
In summary, several systems are in place to detect fluctuations
in the intracellular and/or extracellular availability of nutrients and
hence initiate an autophagic response. However, it remains to be
explored which among these systems preferentially respond to
a global nutrient limitation (which may be caused by a reduction
in blood supply) rather than to changes in the abundance of a
specific molecule (which may be the result of precise metabolic
perturbations). Moreover, it is not yet known whether nutrient
sensors have similar activation thresholds in all cell types. It is
reasonable to expect that distinct AMPK isoforms, the composi-
tionofmTORC1, the subcellular localizationof acetyltransferases
and sirtuins, as well as the expression pattern of GPCRs, ulti-
mately impact on the fine regulation of autophagy.
Induction of Autophagy by Metabolic Restriction In Vivo
Although culturing cells in the absence of glucose, amino acids,
or all nutrients constitutes a valid model for the induction of
autophagy in vitro, such drastic alterations in the abundance of
extracellular supplies do not occur in vivo, at least in mammals.
Maintaining mice for 24–48 hr in the absence of food (but with
free access to water) induces autophagy in close-to-all nucle-ated cells of the body while causing a reduction of 10%–20%
in body weight (Mizushima, 2009). Yet, this does not cause ama-
jor depletion in the circulating levels of amino acids or massive,
life-threatening hypoglycemia because of the autophagy-depen-
dent mobilization of cellular stores and the systemic response to
starvation involving hepatic and muscular reserves (He et al.,
2012; Kuma et al., 2004). Indeed, in multicellular eukaryotes,
the composition of the extracellular milieu is preserved by multi-
ple homeostatic circuits. Moreover, the cellular availability of nu-
trients is not mainly dictated by their abundance but, rather, by
the regulation of their uptake via specific transporters expressed
on the plasma membrane (Wieman et al., 2007). Thus, the
expression levels and activity of the cellular systems that ensure
the uptake of various nutrients, including glucose and amino
acids, are regulated by several growth factors as well as by
neuroendocrine circuits (Kim and Lee, 2014) (Figure 3).
In conditions of acute starvation, the circulating levels of insu-
lin (INS) and insulin-like growth factor 1 (IGF1) decrease while
those of the insulin-like growth factor binding protein 1 (IGFBP1,
an IGF1 antagonist) and glucagon (GCG) increase (Cheng et al.,
2014). The consequent reduction of INS and IGF1 signaling
may contribute to the inhibition of nutrient uptake and mTORC1
inactivation, favoring a compensatory autophagic response that
preserves bioenergetic homeostasis (Troncoso et al., 2012).
Similarly, the absence of growth factors not only limits glucose
uptake upon the downregulation of plasma membrane trans-
porters (Wieman et al., 2007), but also inhibits downstream
signaling via the AKT1/mTORC1 pathway and promotes the
interaction between the catalytic subunit of class I PI3Ks and
the small GTPase RAB5A, hence favoring the activating interac-
tion of the latter with VPS34 (Dou et al., 2013). A similarCell 159, December 4, 2014 ª2014 Elsevier Inc. 1269
suppression of AKT1/mTORC1 signaling occurs upon the activa-
tion of protein kinase A by GCG (Kondomerkos et al., 2005).
Thus, drops in the extracellular availability of INS, IGF1, and
growth factors coupled to increased GCG signaling provoke a
robust autophagic response. Accordingly, the postnatal in-
crease in circulating INS levels resulting from breast feeding sup-
presses maladaptive autophagy in cardiomyocytes, as it has
been shown inmice harboring a cardiomyocyte-specific deletion
of Irs1 and Irs2 (coding for two key transducers of INS and IGF1
signals) (Riehle et al., 2013). Moreover, the exogenous provision
of IGF1 reverts some of the metabolic effects of starvation in
mice (Cheng et al., 2014).
Epinephrine is secreted by adrenal glands when hypotha-
lamic neurons detect a drop in circulating glucose levels, and
the consequent activation of b-adrenergic GPCRs in peripheral
tissues promotes the mobilization of triglyceride stores through
a mechanism that involves autophagy (Lizaso et al., 2013).
Moreover, epinephrine deficiency (owing to the ablation of the
gene coding for phenylethanolamine N-methyltransferase)
causes severe hepatic steatosis coupled to deficient autophagy
and impaired triglyceride usage yet does not affect glucose ho-
meostasis (Sharara-Chami et al., 2012). Intriguingly, starvation
is coupled to a major increase in circulating triglycerides, and
the free fatty acids resulting from their catabolism (such as
oleate and palmitate) may also stimulate autophagy (Shen
et al., 2012).
Additional nutrient-responsive neuroendocrine mediators,
including leptin, adiponectin, ghrelin, myonectin, and others,
may affect autophagic responses, establishing a complex
network of autophagy-stimulatory and autophagy-inhibitory sig-
nals. Prominent autophagy inducers including starvation, phys-
ical exercise, rapamycin, resveratrol, and spermidine (a natural
polyamine) cause a reduction in circulating leptin levels (He
et al., 2012). In the case of exercise, this effect is lost in mice ex-
pressing a variant of B cell CLL/lymphoma 2 (BCL2) that blocks
stimulus-induced (but not baseline) autophagy (He et al., 2012).
Conversely, the reduction of circulating leptin caused by fasting
occurs normally in Atg7/ mice (Karsli-Uzunbas et al., 2014).
The knockout of adiponectin (ADIPOQ), encoding a hormone
secreted by the adipose tissue (and placenta), reportedly inhibits
autophagy in the myocardium while aggravating diet-induced
obesity and the consequent cardiac dysfunction, a series of ef-
fects that can be prevented by the administration of rapamycin
(Guo et al., 2013b). Ghrelin, also known as the ‘‘hunger hor-
mone,’’ is produced by the gastrointestinal tract when the
stomach empties. In vitro, ghrelin mediates both autophagy-
activating and autophagy-inhibitory functions, reflecting its abil-
ity to inhibit proteasomal protein degradation and AMPK,
respectively (Bonfili et al., 2013; Wang et al., 2014). It remains
to be determined which of these functions predominate in vivo
in physiological versus pathological scenarios. Finally, myonec-
tin (a skeletal muscle-derived hormone encoded by FAM132B)
suppresses hepatic autophagy upon the stimulation of AKT1/
mTORC1 signaling (Seldin et al., 2013). Taken together, these
observations indicate that several neuroendocrine mediators
regulate autophagy.
Interestingly, autophagy is also coupled to unconventional
secretory pathways, mediating the release of a series of soluble1270 Cell 159, December 4, 2014 ª2014 Elsevier Inc.molecules, including diazepam-binding inhibitor (DBI, best
known as ACB), interleukin-1b, and interleukin-18 (Zhang and
Schekman, 2013). Thus, autophagy is regulated by several
neuroendocrine circuits that sense systemic nutrient availability
at the same time that it affects the release of various mediators,
including hormones, neurotransmitters, and cytokines. The intri-
cacies of this regulatory network are not yet fully understood and
require in-depth exploration.
Despite the limitation of in vitro studies, numerous examples
suggest that energy sensors with autophagy-modulatory prop-
erties in vitro are also required for autophagy induction by caloric
restriction or fasting in vivo. A ketogenic diet (i.e., a high-fat,
low-carbohydrate, and low-protein diet supplemented with
ketogenic essential amino acids) inhibits mTORC1 in vivo and
stimulates autophagy (Xu et al., 2013). Moreover, AMPK is indis-
pensable for myocardial adaptation to caloric restriction in mice
(Chen et al., 2013), and sirtuins are required for the autophagy-
dependent beneficial effects of nutrient deprivation in nonmam-
malian model organisms (Morselli et al., 2011) and perhaps in
mice (Mercken et al., 2014).
Interestingly, mice that are starved for 24 hr exhibit a signifi-
cant decrease in cytosolic acetyl-CoA in skeletal and cardiac
muscles (but not in the brain) (Marin˜o et al., 2014), suggesting
that the overall nutrient status may affect the abundance of spe-
cific intracellular metabolites. Similarly, acetyl-CoA levels drop
in the livers of mice experiencing prolonged periods of caloric
restriction (Hebert et al., 2013). It is not yet known whether
this effect stems directly from decreased nutrient availability
or rather reflects a drop in AKT1-dependent activation of
ACLY as a consequence of limited INS and IGF1 signaling
(Lee et al., 2014).
It appears that (some of the) nutrient sensors originally identi-
fied in vitro contribute to the regulation of autophagic responses
in vivo. However, we can anticipate that future studies will
unravel the major impact of nervous, endocrine, and paracrine
signals in the control of autophagy at the whole-body level,
contributing to the sophisticated homeostatic regulation that
renders the organism adaptable to changes in the quantity and
quality of nutrient supplies.
Metabolic Consequences of Autophagy
In Individual Cells
Most studies on the metabolic consequences of autophagy
compare wild-type cells with cells in which genes encoding
essential components of the autophagic machinery have
been deleted by homologous recombination or have had
their products depleted by RNA interference. Though this
approach may provide reliable results in short-term experi-
ments (performed within a few days after knockout or
knockdown), it is likely to generate misleading information in
long-term settings. Indeed, autophagic defects cause the
accumulation of malfunctioning mitochondria and redox-
active protein aggregates that, in the long term, have wide-
spread metabolic consequences, including a reduction in
mitochondrial ATP synthesis and an increased generation of
genotoxic ROS.
In the presence of an intact p53 system, autophagy-deficient
cells exhibit impaired proliferation in vivo (Rosenfeldt et al.,
Figure 4. Regulation of Cellular and Organismal Autophagic
Responses
(A) When the availability of nutrients in the extracellular fluids drops below a
threshold level, sensors expressed by most (if not all) cells are activated and
dispatch an autophagy-stimulating stimulus via one or more signal trans-
ducer(s). The consequent mobilization of intracellular stores restores, at least
to some extent, nutrient availability, resulting in the suppression of autophagy-
promoting signals.
(B) Besides mediating direct pro-autophagic effects on virtually all cells, drops
in the circulating levels of several nutrients stimulate specific cell types to
release neuroendocrine mediators that induce autophagy. These mediators
generally trigger autophagic responses in the liver, adipose tissue, or skeletal
muscle, resulting in the restoration of systemic nutrient availability and hence
in the feedback inhibition of both central and cellular autophagic responses.2013), perhaps linked to reduced glucose uptake and glycolytic
flux (Lock et al., 2011). Moreover, defects in the autophagic ma-
chinery result in a marked dependency of BrafV600E-driven lung
carcinoma cells on glutamine (Strohecker et al., 2013), whereas
they lower mitochondrial oxygen consumption and the levels
of Krebs cycle intermediates in the context of KRAS-driven
carcinogenesis (Guo et al., 2011).
Autophagy most often delays the transition between a revers-
ible alteration of metabolic homeostasis and the generation of
signals that irreversibly commit the cell to death (Galluzzi et al.,
2014). Besides counteracting the depletion of energy-rich sub-
strates, which is per se potentially lethal, autophagy limits the
accumulation of permeabilized mitochondria, the organelles
that regulate the intrinsic pathway of apoptosis and contribute
to several instances of regulated necrosis (Galluzzi et al., 2012).
One aspect of autophagy regulation that requires further scru-
tiny is feedback inhibition. Indeed, it is reasonable to expect that
amino acids and other energy-rich metabolites resulting from
autophagy-dependent catabolic reactions act on intracellular
nutrient sensors to inhibit autophagic responses (Figure 4). By
reducing the autophagic flux (irrespective of the conditions that
increased it), such a phenomenon may contribute to the shut-
down of adaptive responses to stress that marks the recovery
of homeostasis.In Whole Organisms
One problem with the interpretation of data from mouse models
bearing tissue-specific knockouts of genes encoding essential
components of the autophagic machinery is that autophagy
is a key process and its complete suppression invariably
entails major metabolic and nonmetabolic alterations. Therefore,
studies of the ablation of genes such asAtg5 andAtg7 in specific
cell types, including subpopulations of hypothalamic neurons,
pancreatic b cells, adipocytes, hepatocytes, or myocytes (Kim
and Lee, 2014), may provide deeper insights into the impact
of degenerative processes affecting such cells rather than the
physiological contribution of autophagy to metabolic control.
Recently, the effects of the conditional deletion of Atg7 at the
whole-body level have been explored by expressing a ubiquitous
transgene coding for an inducible variant of the Cre recombinase
inAtg7flox/floxmice. In this setting, tamoxifen administration in the
drinking water results in the systemic excision of both floxed
Atg7 alleles (Atg7D/D genotype) (Karsli-Uzunbas et al., 2014).
Disabling autophagy in 8- to 10-week-old mice promotes an
acute immunodeficiency syndrome that increases the suscepti-
bility of mice to lethal staphylococcal infections (10% mortality
2 weeks after the administration of tamoxifen), and degenerative
processes affecting all organs (notably the brain) account for the
demise of all animals 6–15 weeks postknockout (Karsli-Uzunbas
et al., 2014). Of note, two of the early consequences of Atg7
deletion are the absence of liver glycogen and the replacement
of white with brown adipose tissue. At this stage, i.e., 10 days af-
ter knockout, Atg7D/D mice are very sensitive to a short period
(24 hr) of starvation. In particular, they exhibit profound hypogly-
cemia, fail to mobilize fatty acids, and succumb to starvation
while manifesting massive hepatic damage (as indicated by a
surge in the circulating levels of hepatic enzymes) and severe
muscle wasting, as well as DNA damage responses in hepato-
cytes and myocytes. In this setting, glucose supplementation
is sufficient to postpone death and muscle wasting, supporting
the notion that Atg7D/D mice truly die from hypoglycemia in
response to short periods of starvation (Karsli-Uzunbas et al.,
2014). Taken together, these results suggest that the severe
consequences of a complete, irreversible inhibition of the auto-
phagic machinery prevent metabolic adaptations to fasting.
The metabolic consequences of partial autophagy inhibition
have also been explored. A BCL2 variant in which three amino
acids (i.e., T69, S70, and S84) have been substituted with alanine
residues (referred to as BCL2AAA) cannot be phosphorylated
by JNK1. These mutations prevent the phosphorylation-depen-
dent breakdown of BCL2/BECN1 complexes, hence allowing
for baseline, but not stimulus-induced, autophagy (He et al.,
2012). Thus, mice expressing BCL2AAA at the whole-body level
display lower degrees of exercise-induced autophagy in skeletal
muscles than their wild-type counterparts. This correlates with
reduced physical endurance and a decreased sensitivity of skel-
etal muscles to exercise-induced insulin. Moreover, although a
high-fat diet causes obesity and type 2 diabetes in both control
and BCL2AAA-expressing mice, the beneficial effects of exercise
training on diabetes are lost in the latter. Very similar results were
obtained in Becn1+/ mice (He et al., 2012). These findings sug-
gest that autophagy in skeletal muscles may contribute to the
systemic beneficial effects of exercise.Cell 159, December 4, 2014 ª2014 Elsevier Inc. 1271
Becn1+/ mice of 16–24 months of age also exhibit increased
lipid accumulation in the liver as compared to their age-
matched wild-type counterparts (Amir and Czaja, 2011). More-
over, in a mosaic Atg5 knockout model (in which only a fraction
of tissues, including the liver, exhibit autophagic defects),
hepatocytes became highly loaded with lipid droplets by
19 months of age (Takamura et al., 2011), supporting the idea
that autophagy may counteract steatosis in a cell-autonomous
fashion.
The overexpression of essential components of the autopha-
gic machinery may yield useful information regarding the contri-
bution of autophagy to whole-body physiology, provided that
such a manipulation is not deleterious for specific cell types.
For example, the transgenic expression ofAtg5 under the control
of a universal, moderate promoter extends the lifespan of mice
by 17.2% (Pyo et al., 2013). This suggests that promoting
autophagy to some extent is nontoxic. Importantly, Atg5-over-
expressing mice not only exhibit a lean phenotype, reduced
hepatic levels of triglycerides, increased glucose clearance,
and insulin sensitivity as compared to their wild-type counter-
parts, but are also protected against diet-induced obesity and
insulin resistance (Pyo et al., 2013). These findings support a
general anti-obesity and anti-diabetes role of autophagy.
Nutritional interventions and other (pharmacological or ge-
netic) inducers of autophagy may also be used to manipulate
metabolism in vivo. Ample evidence indicates that caloric re-
striction or specific nutritional manipulations (e.g., methionine re-
striction, polyamine supplementation) can increase the longevity
of nonmammalian organisms (such as yeast, nematodes, and
flies) in an autophagy-dependent manner. Similarly, rapamycin
and several other experimental inducers of autophagy (such as
resveratrol and spermidine) extend the lifespan of nonmamma-
lian species in an autophagy-dependent fashion (Rubinsztein
et al., 2011). Rapamycin also increases the longevity of labora-
tory mice and reverses age-related cardiac dysfunction, even
when administered late in life (Harrison et al., 2009). However,
it has not yet been determined whether autophagy is required
for the lifespan-extending effects of rapamycin on mice. More-
over, rapamycin may promote type 2 diabetes, probably due
to inhibition of mTORC2 (Lamming et al., 2012).
Future studies must determine which, if any, dosing schedule
might reduce the immunosuppressive and pro-diabetic side
effects of rapamycin or whether rapamycin should be replaced
by more specific mTORC1 inhibitors (Li et al., 2014), other drugs
that mimic the effects of caloric restriction (i.e., that reduce
acetyl-CoA levels, such as ACLY inhibitors; stimulate sirtuins,
such as nicotinamide or resveratrol; and/or inhibit acetyltrans-
ferases, such as spermidine) (Madeo et al., 2014), or agents
that specifically activate the autophagic machinery (such as a
cell-permeable peptide that derepresses BECN1) (Shoji-Kawata
et al., 2013). Indeed, although accumulating evidence indicates
that nicotinamide and resveratrol have profound anti-obesity
and anti-diabetes effects (Canto´ et al., 2012; Lagouge et al.,
2006), it remains elusive to what extent such activity is mediated
by autophagy.
Both rapamycin and nicotinamide riboside can be used to
treat experimental mitochondriopathies. In particular, rapamy-
cin improves the clinical course of mice lacking a mitochondrial1272 Cell 159, December 4, 2014 ª2014 Elsevier Inc.respiratory chain subunit (NADH dehydrogenase [ubiquinone]
Fe-S protein 4, 18 kDa, Ndufs4), which develop brain lesions
similar to those associated with the Leigh syndrome (Johnson
et al., 2013). Similarly, nicotinamide riboside causes a signifi-
cant improvement in the symptoms of mice carrying a dominant
mutation in the gene coding for progressive external ophthal-
moplegia 1 (Peo1, a mitochondrial replicative helicase), which
results in progressive mitochondrial myopathy upon the accu-
mulation of mutated mtDNA (Khan et al., 2014). Moreover,
nicotinamide riboside improves the mitochondrial defects
and intolerance to physical exercise of mice expressing a path-
ologic variant of SCO cytochrome oxidase-deficient homolog
2 (Sco2) in the absence of endogenous Sco2 alleles, which
develop a mitochondrial disease model characterized by
impaired biogenesis of cytochrome c oxidase (Cerutti et al.,
2014). Because autophagy plays a major role in mitochondrial
quality control, a chronic increase in autophagy could contribute
to the beneficial effects of these compounds on diseases with
limited therapeutic options. This possibility remains to be
addressed.
In summary, we are currently witnessing the development
of new pharmacological and genetic methods to manipulate
(induce or suppress) autophagy, which should facilitate the
exploration of this key pathway in physiological scenarios. It
will be particularly interesting to examine autophagy by tech-
niques that permit its partial and transient modulation, either in
the entire organism or in defined organs. Beyond mechanistic
insights, such an approach will yield information on the thera-
peutic utility and potential long-term side effects of autophagy-
modulating measures.
Conclusions and Perspectives
Undoubtedly, metabolism regulates autophagy, and autophagy
has a profound impact on metabolism. As a major manifestation
of this tight interrelationship, the autophagy-dependent mobili-
zation of cellular and organismal reserves triggers negative feed-
back circuitries that inhibit autophagy at both the single-cell and
systemic level (Figure 4). Autophagy is a complex process
that requires a major degree of coordination among distinct
molecular systems, ensuring that the initial sequestration of the
autophagic cargo in autophagosomes leads to lysosomal degra-
dation. Indeed, the induction of autophagy by heterogeneous
interventions provokes a relatively homogeneous response
characterized by the activation of specific kinases (AMPK, IKK,
JNK1, TAK1, ULK1, VPS34), the inhibition of others (such
as mTORC1), protein deacetylation reactions (at least in part
ensuring the activation of SIRT1 and/or the inhibition of
EP300), and the reversal of inhibitory interactions such as those
between BECN1 and Bcl-2 family members.
Such a tight coordination may be achieved by several mecha-
nisms, including (but not limited to): (1) mutually stimulatory pro-
autophagic interactions among nutrient sensors (e.g., AMPK and
SIRT1, AMPK and mTORC1), (2) the direct activation of several
pro-autophagic factors by nutrient sensors (e.g., ULK1 and
TFEB, which are regulated by mTORC1), (3) positive interactions
among essential molecules involved in distinct steps of the
autophagic process (e.g., the phosphorylation of BECN1
and AMBRA1 by ULK1; the phosphorylation of AMBRA1 by
mTORC1); and (4) synchronized rearrangements of key factors
in functionally distinct multiprotein complexes. This may explain
why distinct primary signals can stimulate stereotyped changes
in several supramolecular complexes involved in the regulation
of autophagy.
An emerging theme is that autophagy responds to the deple-
tion of a panel of nutrients by mobilizing intracellular reserves.
Still, it is not clear yet whether distinct types of nutrient defi-
ciencies may cause a highly specific and graduated autophagic
response resembling the one triggered by iron deficiency. Thus,
one might speculate that fluctuations in the abundance of spe-
cific nutrients might stimulate an autophagic response (in terms
of autophagic cargo and cell types involved) that differs from the
one induced by indiscriminate caloric restriction. Irrespective of
these and other unknowns, autophagy exerts major homeostatic
control on both cellular and organismal metabolism. Thus, we
anticipate that pathological alterations of autophagy and their
therapeutic correction will occupy a central stage in future
clinical practice.
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